<DOC>
	<DOC>NCT01659892</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Montelukast Chewable Tablet under fed conditions</brief_summary>
	<brief_title>Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Montelukast</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to montelukast or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>